A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia
- PMID: 2648581
A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical